Skip to main content
Caplight Logo









Avivomed

Avivomed

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://avivomed.com/

Last Round

Seed Round

Apr 21, 2026

Total Funding Raised

$32M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Avivomed is a medical device company that develops and commercializes next-generation minimally invasive neuromodulation therapies for patients suffering from obstructive sleep apnea and other chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neuromodulationobstructive sleep apneaOSAmedical deviceimplantable deviceCPAP alternativeminimally invasivesleep apnea treatmentnerve stimulationairway managementclinical-stagesleep techbioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avivomed Comparables

Compare Avivomed with similar companies based on industry and business-model similarity.

Avivomed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lunair Medical
94%
XII Medical
92%
StimAire
89%

Avivomed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 21, 2026
Series ADec 1, 2021

Key People

Founding team and executive leadership

Paul Mazanec

CTO VP Of Research Development

Executive Team

Avivomed Investors

Notable investors and investment history

Avivomed investors
InvestorRounds
F-Prime CapitalSeries A
Hatteras Venture PartnersSeries A
Norwest Venture PartnersSeries A
F-Prime CapitalSeries A
Treo VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 369% MoM, reaching 1.5K.

  • Apr 21, 2026

    $5M round raised

Avivomed Filings

Explore SEC and related filing metadata, where available.

Avivomed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avivomed's valuation, stock price, and market status.

Is Avivomed a public or private company?

Avivomed is a private company.

What is the current stock price of Avivomed?

Avivomed is a private company with no public stock price. No recent secondary market data is available.

How much is Avivomed worth (valuation)?

Valuation information for Avivomed is not publicly available.

Can I buy Avivomed stock?

Avivomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avivomed's last funding round?

Avivomed's most recent funding round was Seed Round on April 21, 2026.

Who are the main investors in Avivomed?

Key investors in Avivomed include F-Prime Capital, Hatteras Venture Partners, Norwest Venture Partners, Treo Ventures.

Will Avivomed IPO soon?

No public IPO plans have been announced for Avivomed.

How can I track Avivomed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avivomed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range18
Year Founded2020
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?